Kentaro Kaneko Selected Research

Eosinophilia

6/2002

Anticonvulsant hypersensitivity syndrome with marked eosinophilia in treatment of diabetic neuropathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kentaro Kaneko Research Topics

Disease

8	Obesity 12/2022 - 01/2016
6	Body Weight (Weight, Body) 01/2022 - 01/2016
4	Inflammation (Inflammations) 01/2020 - 01/2015
3	Insulin Resistance 01/2021 - 01/2016
2	Hypersensitivity (Allergy) 01/2023 - 06/2002
2	AIDS-Related Complex (ARC) 12/2022 - 07/2022
2	Hypoxia (Hypoxemia) 08/2011 - 04/2008
1	Dyspnea (Shortness of Breath) 01/2023
1	Colorectal Neoplasms (Colorectal Cancer) 01/2023
1	Anorexia 01/2023
1	Paresthesia (Dysesthesia) 01/2023
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2023
1	Dementia (Dementias) 01/2023
1	Cognitive Dysfunction 01/2023
1	Colonic Neoplasms (Colon Cancer) 01/2023
1	Rectal Neoplasms (Rectal Cancer) 01/2023
1	Hyperphagia (Overeating) 07/2022
1	Tics (Tic) 03/2020
1	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2020
1	Overnutrition 12/2019
1	Infections 01/2016
1	Hypothermia 12/2012
1	Pain (Aches) 12/2012
1	Hyperglycemia 02/2012
1	Type 2 Diabetes Mellitus (MODY) 02/2012
1	Neoplasms (Cancer) 08/2011
1	Retinal Diseases 04/2008
1	Diabetic Retinopathy (Retinopathy, Diabetic) 04/2008
1	Eosinophilia 06/2002
1	Diabetic Neuropathies (Diabetic Neuropathy) 06/2002

Drug/Important Bio-Agent (IBA)

7	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 02/2012
5	Proteins (Proteins, Gene)FDA Link 01/2023 - 04/2008
4	Peptides (Polypeptides)IBA 01/2023 - 01/2020
4	LeptinIBA 01/2022 - 01/2016
2	GhrelinIBA 01/2023 - 07/2022
2	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 12/2022 - 07/2022
2	Glucagon-Like Peptide 1 (GLP 1)IBA 12/2022 - 07/2022
2	psicose (D-psicose)IBA 12/2022 - 07/2022
2	Monomeric GTP-Binding ProteinsIBA 01/2021 - 01/2016
2	Insulin (Novolin)FDA Link 01/2021 - 02/2012
2	Hormones (Hormone)IBA 01/2020 - 12/2019
2	Cytotoxins (Cytolysins)IBA 03/2015 - 01/2015
2	Interleukin-1 (Interleukin 1)IBA 03/2015 - 01/2015
2	Retinaldehyde (Retinal)IBA 08/2011 - 04/2008
2	Messenger RNA (mRNA)IBA 08/2011 - 04/2008
1	methyllycaconitineIBA 01/2023
1	prolylglycineIBA 01/2023
1	valyltyrosineIBA 01/2023
1	ThermolysinIBA 01/2023
1	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2023
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2023
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2023
1	Capecitabine (Xeloda)FDA Link 01/2023
1	Fura-2 (Fura 2)IBA 12/2022
1	Neuropeptide YIBA 07/2022
1	Blood Glucose (Blood Sugar)IBA 01/2021
1	EndocannabinoidsIBA 01/2020
1	Nicotine FDA Link 01/2020
1	NitroreductasesIBA 01/2020
1	ProdrugsIBA 01/2020
1	OPC-67683IBA 01/2020
1	5-deazaflavinIBA 01/2020
1	Coenzymes (Enzyme Cofactors)IBA 01/2020
1	des-n-octanoyl ghrelinIBA 01/2017
1	ProstaglandinsIBA 12/2012
1	LipidsIBA 12/2012
1	soymorphin-5IBA 02/2012
1	Aquaporins (Water Channels)IBA 08/2011
1	RNA (Ribonucleic Acid)IBA 08/2011
1	Hypoxia-Inducible Factor 1IBA 08/2011
1	Aquaporin 1IBA 04/2008
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2008
1	Anticonvulsants (Antiepileptic Drugs)IBA 06/2002

Therapy/Procedure

2	Oral Administration 01/2023 - 02/2012
2	Therapeutics 01/2023 - 01/2020
1	Drug Tapering 01/2023